Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Letter to the Editor

Do Children Exposed to Human Immunodeficiency Virus but Not Infected Actually Have a More Robust Response to Hepatitis B Vaccination than Their Nonexposed Peers?

Olivia Swann, Ewen M. Harrison
Olivia Swann
Department of General Paediatrics Royal Hospital for Sick Children Yorkhill, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewen M. Harrison
Department of Clinical Surgery University of Edinburgh Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.05508-11
  • Article
  • Info & Metrics
  • PDF
Loading

LETTER

The recent article by Abramczuk et al. is timely (1). With improving access worldwide to antiretroviral (ARV) therapy, an increasing number of children are born who are human immunodeficiency virus (HIV) exposed but uninfected (HEU). Understanding their specific needs will allow health professionals to tailor care appropriately, making research in this area essential.

Although the authors of the above paper allude to antiretroviral use in their discussion, no mention is made of whether the study population was exposed to ARVs in utero. As indicated in the paper, ARV exposure may modulate placental cytokine patterns (2). It would be useful if the authors could comment upon ARV exposure and regimens used.

With regard to the hepatitis B vaccination results (anti-HBs titers), the statistical analysis accompanying Table 1 is a chi-squared test. An assumption of this test is that 80% of the cell counts have an expected frequency of greater than 5. In this case, 33% of the expected cell counts (i.e., 2 out of 6) do not fulfill this assumption. While Fisher's exact test (which could have been used in this circumstance) is significant (P = 0.003), it is incorrect to state that that there is a significant difference specifically between the nonresponder groups, rather than across the table as a whole. Indeed, if the 2 × 3 table is collapsed to nonresponders versus all others, there is no significant difference (Fisher's exact test, P = 0.410).

Instead it is the “very good” responder category (anti-HBs titer of ≥1,000 mIU/ml) that is worthy of comment. In considering very good responders versus all those with titers of <1,000 mIU/ml, the results are significantly different between HEU and nonexposed (NE) children (χ2 = 8.78, df = 1, P = 0.003) (assuming that Table 1, column 3, should read “≥1,000 mIU/ml” and not “≤1,000 mIU/ml”).

HEU children are thus significantly more likely to have a very good response to hepatitis B vaccination than are NE peers. This point is not discussed in the paper. In light of other vaccination research into HEU children, this difference is interesting.

Jones et al. recently examined antibody responses in HEU children in a South African population with prevention of mother-to-child transmission based on a zidovudine and nevirapine regimen. The authors showed lower specific antibody titers to Haemophilus influenzae type B, pertussis, pneumococcus, and tetanus at birth in HEU than in NE neonates (3). Significantly, although the HEU group had lower initial titers, they then mounted more robust antibody responses to pertussis and pneumococcus following routine vaccination. In contrast to the above analyses, this effect was not reported to extend to hepatitis B.

  • Copyright © 2012, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Abramczuk BM,
    2. et al
    . 2011. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin. Vaccine Immunol. 18:1406–1409.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Faye A,
    2. et al
    . 2007. Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin. Exp. Immunol. 149:430–439.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Jones CE,
    2. et al
    . 2011. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 305:576–584.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Do Children Exposed to Human Immunodeficiency Virus but Not Infected Actually Have a More Robust Response to Hepatitis B Vaccination than Their Nonexposed Peers?
Olivia Swann, Ewen M. Harrison
Clinical and Vaccine Immunology Jan 2012, 19 (2) 293; DOI: 10.1128/CVI.05508-11

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Do Children Exposed to Human Immunodeficiency Virus but Not Infected Actually Have a More Robust Response to Hepatitis B Vaccination than Their Nonexposed Peers?
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
Share
Do Children Exposed to Human Immunodeficiency Virus but Not Infected Actually Have a More Robust Response to Hepatitis B Vaccination than Their Nonexposed Peers?
Olivia Swann, Ewen M. Harrison
Clinical and Vaccine Immunology Jan 2012, 19 (2) 293; DOI: 10.1128/CVI.05508-11
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X